Brain Metastases From Differentiated Thyroid Cancer in the Era of Targeted Therapies: A Multi‐Center Retrospective Cohort
Head & Neck · 2025
DOI: 10.1002/hed.70139 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Head & Neck, 2025. Verfasst von Liyona Kampel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Brain Neoplasms, Adenocarcinoma, Follicular. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Brain metastases (BM) of differentiated thyroid carcinoma (DTC) are associated with unfavorable prognosis. This study evaluated BM management strategies and patients' outcomes.
Methods
A retrospective review of patients diagnosed with DTC and BM at Tel Aviv Sourasky and Rabin Medical Centers between 1985 and 2024. Clinical features, histopathology, treatments, and survival data were collected.
Results
Twenty patients were identified: 11 (55%) had papillary thyroid carcinoma, 8 (40%) had follicular carcinoma and 1 had Hurtle cell carcinoma. BM treatments included neurosurgical resection ( n = 9), stereotactic radiosurgery ( n = 14), and whole‐brain radiotherapy ( n = 6). Median survival following BM diagnosis was 16.2 months. Patients who did not undergo surgical resection had significantly shorter survival than those whose BM were resected (13 vs. 80 months, p = 0.03). Survival was also worse among patients receiving systemic therapy at the time BM developed (8.9 vs. 80 months, p = 0.0001).
Conclusion
Unresected BM of DTC and those arising during systemic therapy portend high mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- The Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Otolaryngology Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel.
- Rabin Medical Center, Institute of Oncology, Davidoff Center, Petah Tikva, Israel.
- Rabin Medical Center, Institute of Endocrinology, Diabetes and Metabolism, Petah Tikva, Israel.
- Hadassah Hebrew University Medical Center, Sharett Institute of Oncology, Jerusalem, Israel.
ORCID-Profile: Liyona Kampel
Zitieren
APA
Kampel, L., Edalati, S., Yosefof, E., Warshavsky, A., Horowitz, G., Muhanna, N., Shoffel-Havakuk, H., Robenshtok, E., Popovtzer, A., & Finkel, I. (2025). Brain Metastases From Differentiated Thyroid Cancer in the Era of Targeted Therapies: A Multi‐Center Retrospective Cohort. Head & Neck. https://doi.org/10.1002/hed.70139
Vancouver
Kampel L, Edalati S, Yosefof E, Warshavsky A, Horowitz G, Muhanna N, et al. Brain Metastases From Differentiated Thyroid Cancer in the Era of Targeted Therapies: A Multi‐Center Retrospective Cohort. Head & Neck. 2025. doi:10.1002/hed.70139
BibTeX
@article{Kampel2025,
author = {Kampel, Liyona and Edalati, Shaun and Yosefof, Eyal and Warshavsky, Anton and Horowitz, Gilad and Muhanna, Nidal and Shoffel-Havakuk, Hagit and Robenshtok, Eyal and Popovtzer, Aron and Finkel, Inbar},
title = {Brain Metastases From Differentiated Thyroid Cancer in the Era of Targeted Therapies: A Multi‐Center Retrospective Cohort},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.70139}
}
EUVIMED